June 01, 2012 08:00 ET

Equity Research on Baxter International Inc. and Thermo Fisher Scientific Inc. - Medical Instruments & Supplies Companies Expanding Abroad in Wake of Domestic Headwinds

NEW YORK, NY--(Marketwire - Jun 1, 2012) - has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Medical Instruments & Supplies industry and are offering free analytical research on Baxter International Inc. (NYSE: BAX) and Thermo Fisher Scientific Inc. (NYSE: TMO). Register with us today at to have free access to these research reports.

Companies in the medical Instruments & supplies industry have been facing headwinds at home, as lackluster hospital spending as well as possible reimbursement cuts threaten to eat into sales. Stiff competition has also become a concern for the industry, as companies jockey for a greater market share. Get your free reports on Baxter International Inc. and Thermo Fisher Scientific Inc. at There is no commitment to join. is the Ultimate Trading Environment for investors. If you are considering owning Baxter International Inc. and Thermo Fisher Scientific Inc. then you should sign up for a free membership and our complimentary reports today at Over the last 5 years our returns outpaced any of the major indexes. Sign up today to find out what you are missing.

One bright spot for the industry and companies such as Baxter International Inc. and Thermo Fisher Scientific has been emerging markets. Companies have been able to grow sales abroad which have fueled expansions in some areas. Baxter recently announced a win in China, stating that ADVATE received State Food and Drug Administration approval for the control and prophylaxis of bleeding episodes in those with hemophilia A. Baxter International Inc. report is accessible for free by registering today at

Thermo Fisher has also been focusing abroad, and has stated it will attempt to boost emerging market sales, particularly in Russia, Brazil and South Korea. Thermo Fisher plans to make 25% of revenues from emerging markets by 2016, up considerable from the present 19%. Thermo Fisher Scientific Inc. report is accessible for free by registering today at

The two Medical Instruments & Supplies stocks research reports are available for free by signing up now on


Shine's Rooms is the brain child of David Shine, a 13 year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.

To view our disclaimer, visit this link

Contact Information